AIG
BIVV

American International Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

American International Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-224,095
Closed -$12.1M – 3043
2017
Q4 		$12.1M Buy
224,095
+2,823
+1% +$154K 0.04% 324
2017
Q3 		$12.6M Sell
221,272
-179
-0.1% -$10.5K 0.04% 253
2017
Q2 		$13.3M Buy
221,451
+8,501
+4% +$484K 0.05% 235
2017
Q1 		$11.6M Buy
+212,950
New +$10.5M 0.04% 294

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

American International Group's BIVV Position: Q1 2018 in Review

American International Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 224,095 shares — an estimated $12.1M sold.

American International Group first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $13.3M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • American International Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • American International Group sold 224,095 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $12.1M.
  • American International Group first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • American International Group's Bioverativ Inc. Common Stock position peaked at $13.3M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on American International Group's 13F filing for Q1 2018, filed 7 May 2018.